News & Blog

August 23, 2022 | In The News
Wall Street Journal: Life Sciences Venture Investor MEC Raises $145 Million Fund
August 23, 2022 | Press Release
Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund
July 26, 2022 | Blog Post
Cell Therapy in CNS: Why now?
July 13, 2022 | Press Release
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
May 27, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding
May 18, 2022 | Press Release
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
May 10, 2022 | Press Release
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners
May 04, 2022 | Blog Post
How Lessons Learned During COVID Will Shape the Future of Early Cancer Detection
April 12, 2022 | Press Release
Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson’s Disease
March 01, 2022 | In The News
ALS News Today: ProJenX Launches, Will Develop ALS Therapy Prosetin